Vaccine pauses eagerly awaiting new guidelines



[ad_1]

Vaccine pauses eagerly awaiting new guidelines

Sweden’s suspension of Astra Zeneca’s covid-19 vaccine is expected to be lifted early next week. The Public Health Agency is considering excluding certain groups from vaccination with Astra drugs.
– It is important both to make the vaccine program as safe as possible and to maintain the willingness to vaccinate, says vaccine researcher Farshid Jalavand.

The Astra Zeneca vaccine has a less protective effect and is less resistant to the South African covid-19 mutation. Now serious health risks are also emerging. “It is important to the willingness to vaccinate that the authorities take all risks very seriously,” says Farshid Jalavand, a vaccine researcher at Lund University.

The signs are in conflict on the health risks of Astra Zeneca’s coronavine vaccine. The European Medicines Agency (EMA) has established that the vaccine is safe and that those affected by blood clots and internal bleeding after vaccination are very few.

Premium content

A premium package is required to view this content. Please allow javascript on this page to buy one.

[ad_2]